Clinical Study
Breaking the Taboo: Illicit Drug Use among Adolescents with Type 1 Diabetes Mellitus
Table 1
Clinical characteristics of patients with diabetes and controls.
| | | Diabetic patients
() | Healthy controls
() | level |
| | Female (%) versus male (%) | 102 (48.8) versus 107 (51.2) | 5982 (50.6) versus 6132 (49.3) | |
| Age (year)
Mean ± SD | 16.5 ± 1.0 | 16.9 ± 0.9 | |
| | 15-16 years (%) | 98 (47.1) | 6050 (49.9) | |
| | 17-18 years (%) | 110 (52.8) | 5055 (50.0) | |
| Diabetes duration (year)
Median (interquartile range) | 6 (3–10) | — | |
| | HbA1c (%) | | — | | | 6–8% | 89 (47) | | | | 8–10% | 62 (33) | | | | 10–12% | 30 (16) | | | | >12% | 8 (4) | | |
| Insulin (units/day)
Median (interquartile range) | 50 (30–65) | — | |
| | Insulin pump therapy (%) | 79/183 (43) | — | |
|
|
Response rate of 189/209; response rate of 183/209.
|
